Health Canada drug identification number

DIN 02488159 — MINT-SPIRONOLACTONE 100 MG

MINT-SPIRONOLACTONE is a tablet of Spironolactone marketed by MINT PHARMACEUTICALS INC. The full Spironolactone monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02488159
Brand name
MINT-SPIRONOLACTONE
Active ingredient
Spironolactone
Strength
100 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
MINT PHARMACEUTICALS INC
Health Canada status
MARKETED
Drug class
Aldosterone antagonist (potassium-sparing diuretic)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Spironolactone products

DINBrandStrengthFormManufacturerStatus
02518848 JAMP SPIRONOLACTONE 100 MG TABLET JAMP PHARMA CORPORATION MARKETED
02518821 JAMP SPIRONOLACTONE 25 MG TABLET JAMP PHARMA CORPORATION MARKETED
02488140 MINT-SPIRONOLACTONE 25 MG TABLET MINT PHARMACEUTICALS INC MARKETED
00613223 TEVA-SPIRONOLACTONE 100 MG TABLET TEVA CANADA LIMITED MARKETED
00613215 TEVA-SPIRONOLACTONE 25 MG TABLET TEVA CANADA LIMITED MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.